Narachai Julanon

Dr. Narachai Julanon

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2023 in Experimental Dermatology
Verified
Journal Article
Open access
LCLeena Chularojanamontri
Leena Chularojanamontri
KRKrittaya Rattanakorn
Krittaya Rattanakorn
NJNarachai Julanon
Narachai Julanon
MCMati Chuamanochan
Mati Chuamanochan
Chris EM GriffithsChris EM Griffiths
Chris EM Griffiths
Pustular psoriasis is characterised by eruptions of neutrophilic sterile pustules. The European Rare and Severe Psoriasis Expert Network consensus defines pustular psoriasis into three subtypes; generalised pustular psoriasis (GPP), palmoplantar pustulosis and acrodermatitis continua of Hallopeau (ACH). Mixed forms are categorised according to their predominant features. However, the Japanese Dermatological Association includes ACH under the diagnosis of GPP. This article aims to review the similarities and differences between ACH and GPP. Based on our review, interleukin (IL)‐36RN mutations, the most frequent genetic findings in pustular psoriasis are found most commonly in GPP, followed by ACH. Genotypes of IL‐36RN mutations among GPP patients and ACH patients are different between European and Asian ethnicities. IL‐36 signalling pathway is the main mechanism. Metabolic diseases are common comorbidities and joint involvement can occur in 20.5%–36.4% of both conditions. Associated plaque psoriasis is more common in GPP than in ACH. Generally, ACH, even the generalised type, does not have systemic inflammation whereas GPP can occur with or without systemic inflammation. ACH can occur before, simultaneously, or after the development of GPP. However, response to treatment for GPP and ACH even in the same patients appear to be different. ACH seemed to be more recalcitrant to treatment than GPP but severe flare of GPP can lead to morbidity and mortality. Although GPP and ACH share genotypes and pathogenesis, we believe that ACH should be classified separately from GPP, and not under diagnosis of GPP. Future research is warranted to satisfactorily distinguish the two conditions.

5 March 2025 in Nutrition Reviews
Verified
Journal Article
Open access
Chanita UnhapipatpongChanita Unhapipatpong
Chanita Unhapipatpong
NJNarachai Julanon
Narachai Julanon
PSPrapimporn Chattranukulchai Shantavasinkul
Prapimporn Chattranukulchai Shantavasinkul
NPNint Polruang
Nint Polruang
PNPawin Numthavaj
Pawin Numthavaj
ATAmmarin Thakkinstian
Ammarin Thakkinstian
Context: Dyslipidemia is a major risk factor for atherosclerotic cardiovascular disease (ASCVD), and curcumin may help improve lipid metabolism. Objective: This umbrella review and updated meta-analysis assessed the effects of curcumin supplementation on lipid profiles. Data Sources: Electronic databases (Medline, Scopus, Cochrane, and Google Scholar) were searched through March 31, 2023, without language restrictions. Data Extraction: Two independent authors selected eligible randomized controlled trials (RCTs) involving curcumin supplementation compared with placebo, measuring total cholesterol (TC), low-density-lipoprotein cholesterol (LDL-c), high-density-lipoprotein cholesterol (HDL-c), and triglyceride (TG) levels. Data Analysis: This study identified 26 systematic reviews and meta-analyses (MAs) that met the inclusion criteria for the umbrella review. Of these, 53 RCTs, with a corrected coverage area of 9.76% indicating a moderate degree of overlap, were included for re-pooling. Additionally, this study found 19 more RCTs, bringing the total number of studies for the updated MAs to 72. Results: Curcumin significantly reduced TC, LDL-c, and TG, with mean differences (MDs) of -7.76 mg/dL (95% CI: -11.29, -4.22; I2 = 97%), -5.84 mg/dL (95% CI: -11.63, -0.05; I2 = 98%), and -13.15 mg/dL (95% CI: -17.31, -8.98; I2 = 94%), respectively, and increased HDL-c by 2.4 mg/dL (95% CI: 1.22, 3.57; I2 = 94%). The reductions in LDL-c and TG reached the minimally clinically important differences (MCIDs). However, the reduction in TC and increase in HDL-c did not meet their respective MCIDs. Subgroup analysis showed greater lipid improvements in patients with metabolic-related diseases, particularly type 2 diabetes. Enhanced bioavailability forms of curcumin, supplementation for at least 8 weeks, and exercise yielded additional benefits. Conclusion: The study confirmed that curcumin has an anti-lipidemic effect on patients with noncommunicable diseases. A form of curcumin with enhanced bioavailability is preferred, and supplementation for at least 8 weeks, along with exercise, may be used as an accessible approach to reduce the risk of ASCVD. Systematic Review Registration: PROSPERO registration no. CRD42023415577.

11 January 2022 in Clinical and Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
CCCharoen Choonhakarn
Charoen Choonhakarn
SCSuteeraporn Chaowattanapanit
Suteeraporn Chaowattanapanit
NJNarachai Julanon
Narachai Julanon
PLPanita Limpawattana
Panita Limpawattana

23 June 2023 in Foods
Verified
Journal Article
Open access
PDF file
NJNarachai Julanon
Narachai Julanon
BTBen Thiravetyan
Ben Thiravetyan
Chanita UnhapipatpongChanita Unhapipatpong
Chanita Unhapipatpong
NXNutchapon Xanthavanij
Nutchapon Xanthavanij
TKThanachit Krikeerati
Thanachit Krikeerati
MSMongkhon Sompornrattanaphan
Mongkhon Sompornrattanaphan
This cross-sectional study aimed to investigate the prevalence and clinical characteristics of cross-reactivity and co-allergy to other plant foods among adult patients with IgE-mediated banana allergy in Thailand. A structured questionnaire was used to assess clinical reactivity, and cross-reactivity diagnoses were based on reactions occurring within 2 years of banana allergy onset, within 3 h of intake, and confirmed by allergists. Among the 133 participants, the most commonly associated plant foods with clinical reactions were kiwi (83.5%), avocado (71.1%), persimmon (58.8%), grapes (44.0%), and durian (43.6%). Notably, 26.5% of the reported reactions to other plant foods were classified as severe. These findings highlight the common occurrence of cross-reactivity/co-allergy to other plant foods in banana-allergic patients, with a significant proportion experiencing severe reactions. Travelers to tropical regions should be aware of this risk and advised to avoid specific banana cultivars and plant foods with reported high cross-reactivity. The inclusion of self-injectable epinephrine in the management plan for patients with primary banana allergy should be considered due to the substantial proportion of reported severe reactions and the wide range of clinical cross-reactivity and co-allergy observed.

1 February 2022 in Journal of Taibah University Medical Sciences
Verified
Journal Article
Open access
NJNiporn Jariyakulwong
Niporn Jariyakulwong
NJNarachai Julanon
Narachai Julanon
CSCharupong Saengboonmee
Charupong Saengboonmee
This report aims to demonstrate and remind healthcare providers that, despite being considered eradicated in a specific area, leprosy can still be found due to its unusually long incubation period. A case of leprosy has been reported in a 48-year-old Thai woman who presented classic dermatological and neurological symptoms. A physical examination and slit smear preparation with acid-fast staining was performed to fulfil the diagnostic criteria of the World Health Organization (WHO). Therapeutic regimens were prescribed according to WHO recommendations. A patient was diagnosed with leprosy given that all cardinal signs of WHO diagnostic criteria were met after both physical and microscopic examinations. Physical examination of the skin lesions revealed the lepromatous type. Slit smear preparation of the lesions revealed abundant acid-fast bacilli. The patient has been living solely in an area where leprosy has been practically eradicated, with no new cases reported. The most likely cause of her infection is her close contact with a leprosy-infected family member 30 years ago, with whom she shared a house for a week. This report describes a rare case of leprosy with a long incubation period in a non-endemic area. Only non-human primates have had such an unusually long incubation period, which is extremely rare in humans. This information reminds healthcare providers that leprosy is not a disease of the past, and a careful surveillance program for leprosy remains necessary, even in eradicated areas.

22 March 2024 in Experimental Dermatology
Verified
Journal Article
Closed access
LCLeena Chularojanamontri
Leena Chularojanamontri
NSNarumol Silpa‐Archa
Narumol Silpa‐Archa
BPBensachee Pattamadilok
Bensachee Pattamadilok
NJNarachai Julanon
Narachai Julanon
MCMati Chuamanochan
Mati Chuamanochan
PAPravit Asawanonda
Pravit Asawanonda